Introduction: The etiological and pathogenic factors responsible for coronary artery ectasia (CAE) are unclear. Therefore, we aimed to compare subjects with and without CAE with respect to resistin levels and determine whether resistin plays a role in the aetiology or pathogenesis of CAE.
INTRODUCTION
Coronary artery ectasia (CAE) is defined as coronary artery dilatation that is at least 1.5 times larger than the normal adjacent segments or the largest coronary artery diameter (1) . The term ectasia describes diffuse dilatation of the coronary artery, and focal dilatation is termed as coronary aneurysm (2) . Primarily caused by atherosclerosis (50% of cases), it mainly occurs secondary to congenital malformations, connective tissue diseases, vasculitic syndromes and collagenopathies and following the coronary artery revascularization procedures (3) . Histopathologically, ectatic segments are characterized by a marked degradation of medial collagen and elastin fibrils and the disruption of internal and external elastic laminae [4] . In addition, alterations resembling advanced atherosclerosis have also been described, including lymphocyte and monocyte infiltration in the media and adventitia layers, neovascularization and intramural haemorrhage (5) . Enzymatic degradation of the media layer is the key pathogenetic factor for the development of CAE. Other factors related to the etiopathogenesis of the disorder include inflammatory factors (adhesion molecules, C-reactive protein, leukotrienes and adipokines), rennin-angiotensin system, nitric oxide and homocysteine (6) .
Adipokines are a group of inflammatory proteins released primarily by adipocytes or the adipose tissue. Resistin (resistance to insulin) was first detected in 2001, when it was defined as a protein that serves as a bridge between obesity and diabetes by leading to insulin resistance (7) . It is released by the adipose tissue in mice, whereas its primary sources in humans are peripheral blood mononuclear cells, macrophages and bone marrow cells (8, 9) . Human resistin is a 12.5 kDa cysteine-rich peptide with a 108-amino-acid-long mature sequence (10) . A large number of recent studies have suggested that resistin plays a role in many mechanisms responsible for atherosclerosis, including thrombosis, angiogenesis, smooth muscle cell migration and proliferation, endothelial dysfunction and inflammation, the latter two being the leading causes. In addition, in vitro experimental and clinical studies have investigated the role of resistin in the pathogenesis of atherosclerosis and coronary artery disease and in the prediction of major adverse cardiovascular events.
To the best of our knowledge, however, there are no other studies examining the role of resistin in CAE, a condition known to share a similar etiopathogenesis with coronary artery disease. The aim of this study was to explore resistin levels and investigate whether it plays a role in the etiopathogenesis of the disease.
PATIENTS and METHODS

Patient Population
The study subjects were selected from a patient population that underwent coronary angiography at our clinic between May 2012 and June 2013. Forty-two patients were diagnosed to have CAE, whereas 39 patients with angiographically normal coronary arteries were included as the control group. The study was approved by the local ethics committee and conducted in compliance with the Helsinki declaration. All the study subjects were informed about the study and provided written informed consent.
Inclusion Criteria
Forty-two patients having coronary arteries that were ≥ 1.5 times larger than the segments regarded as normal in a generalized manner along the coronary tree were placed in the ectasia group. The control group comprised 39 patients with similar risk factors and demographic properties and angiographically normal coronary arteries and flow properties.
Exclusion Criteria
In addition to the patients with acute coronary syndrome or a history of coronary revascularization, patients with connective tissue diseases, Kawasaki disease, inflammatory bowel disease, vasculitis, malignancy, heart failure (EF < 50%), chronic renal failure, chronic liver disease, chronic obstructive lung disease, infections or coronary plaques > 20% in coronary angiography were excluded from the study.
Study Design
The demographic characteristics of the patients were recorded and their medical history was taken. The risk factors for atherosclerosis and current drugs used by the patients were questioned. All the patients underwent a routine physical examination and blood pressure measurements were taken in addition to length, weight, waist circumference and body mass index measurements. Complete blood count, serum biochemistry, serum lipid panel and resistin levels were measured. The ejection fraction of the heart was calculated using Vivid 7.0 (GE Ultrasound, Horten, Norway) by the Simpson's biplane method of discs in a 2-dimensional echocardiographic examination.
Assessment of CAE with Coronary Angiography
Coronary angiography was performed via femoral artery puncture using the Philips Angioscop X-Ray device (Integris BH5000, Philips Medical Systems, Best, The Netherlands) in all the patients. All coronary angiography procedures were performed using the Judkins technique and 6F catheters but without any coronary vasodilator. The coronaries were imaged from the cranial and caudal angles to acquire right and left anterior oblique images. Two senior cardiologists, who were blinded to the demographic and clinical features as well as the biochemical results of the patients, reviewed all the angiographic sequences. Iohexol (Omnipaque, Ireland) was used as the contrast agent in all the patients. By convention, coronary arteries that were at least 1.5 times larger than the adjacent normal segments or the greatest coronary artery diameter were considered ectatic (1) . CAE patients were divided into subgroups in accordance with the Markis classification system as follows: Type 1 CAE, diffuse ectasia in two or three vessels; Type 2 CAE, diffuse ectasia in one vessel and localized ectasia in at least one other vessel; Type 3 CAE, diffuse ectasia in one vessel; Type 4 CAE, localized and segmentary ectasias.
Resistin Measurement
Serum samples were collected after coronary angiography, centrifuged at 14000 rpm for 5 min, and stored at -70°C until the assay. A double-antibody sandwich enzyme-linked immunosorbent assay (ELISA) method using the Human Resistin ELISA kit (Hangzhou Eastbiopharm, China) was used to measure the serum resistin levels.
Statistical Analysis
Study data were analysed using SPSS for Windows 16.0 (Chicago, Ill, USA). Here the mean ± standard deviation or median (minimum-maximum) are used for expressing the continuous variables, whereas the numbers and percentages are used for the categorical variables. The chi-square test was used to compare categorical variables, whereas the KolmogorovSmirnov test was used to test the normality of data. Groups were compared using the Independent t-test or Mann-Whitney U test. A p value less than 0.05 was considered statistically significant.
RESULTS
Among the 81 subjects enrolled, 42 (15 F, mean age 60.4 ± 9.0 years) formed the ectasia group and 39 (22 F, mean age 56.2 ± 10.7 years) formed the control group. There were no significant differences between the groups with respect to the demographic variables and atherosclerosis risk factors. No significant differences were observed between both the groups with regard to waist circumference, body mass index, fasting serum glucose and lipid panel. Ejection fractions of both the groups were similar (Table 1) . Although the rate of cardiovascular drug use for any reason was higher in the ectasia group, the difference did not reach statistical significance (Table 2 ).
According to the Markis classification, 15 patients were placed in Group 1, 12 patients in Group 2, 8 patients in Group 3 and 7 patients in Group 4. The rate of CAE was 2.02 ± 0.8, with the left anterior descending artery being the most common vessel to be involved (81%). The corresponding rates for the right coronary artery and circumflex artery were 64% and 57%, respectively. Serum resistin levels were significantly higher in the CAE group than those in the control group [mean 703.5 ± 828.1 ng/L, median 379.5 (40-4092) ng/L and mean 313.5 ± 252.6 ng/L, median 256 (30-1244) ng/L, respectively; p= 0.001). 
DISCUSSION
This study primarily demonstrated that subjects with CAE had significantly higher serum resistin levels compared with the control subjects who had normal coronary arteries on angiography.
CAE has a reported rate of 0.2% to 5.3% in different series (11) (12) (13) . Atherosclerosis is the primary factor leading to coronary artery ectasia and accounts for more than 50% of cases (1, 14) . In addition, vasculitic syndromes, of which Kawasaki is the main disorder in children, collagenopathies, congenital malformations, infections, familial hypercholesterolemia and coronary artery revascularization procedures have been held responsible for the aetiology of this condition [15, 16] . Histopathologically, ectasia and atherosclerosis have important common properties. Atheromatous plaque formation, degradation of medial elastic fibrils, disruption of elastic laminae and smooth muscle hyalinization are the main findings in both the conditions [4, 17] . Histopathological findings suggest that ectasia represents a specific remodelling response as a result of local plaque formation in coronary arteries (18) (19) (20) . Previous studies have investigated the relationship between CAE and inflammatory factors, including adhesion molecules, C-reactive protein, vascular endothelial growth factor, leukotrienes and cytokinesand among adipokines and adiponectin (21) (22) (23) (24) (25) (26) (27) (28) . However, there are no studies that have specifically sought out the relationship between CAE and serum resistin levels in adults.
Resistin is a cysteine-rich inflammatory protein in a polypeptide structure from the adipokine family, the role of which was first established in the emergence of insulin resistance and the development of diabetes mellitus (7) . Following the discovery of Reilly et al. that high resistin levels are associated with an increased coronary calcium score, the relationship of both the conditions has begun to attract attention (29) . Studies in literature have examined the role of resistin in stable angina pectoris, acute coronary syndrome (ACS) development and the prediction of myocardial ischaemia following an ACS (30) (31) (32) (33) (34) . On the other hand, Wang et al. reported that the resistin level increased in a stepwise fashion with the increasing number of coronary arteries stenosis to over 50% in patients with stable coronary artery disease (35) . Higher levels of resistin have been found to be linked to the occurrence of adverse events, such as cardiovascular death, myocardial infarction and restenosis in patients undergoing percutaneous coronary intervention (36, 37) . Korah et al. reported that resistin levels significantly increased especially in ACS patients with type 2 diabetes mellitus and therefore it may be used as a diagnostic marker for diagnosing ACS (38) . Resistin impairs endothelial functions and causes the uptake of oxidized low density lipoprotein cholesterol and the formation of foam cells after being released by macrophages [39] [40] [41] . Resistin upregulates the release of adhesion molecules, increases the secretion of proinflammatory factors such as tumour necrosis factor-α, interleukin-6, interleukin-12, nitric oxide, endothelin-1 and matrix metalloproteinases and induces angiogenesis by increasing vascular epithelial growth factor (42) (43) (44) (45) (46) (47) . It has also been reported that resistin exerts a prothrombotic effect by inducing the secretion of tissue factor (48) . Liu R et al., in a study investigating the relationship between adipokines and CAE in children with Kawasaki disease, found a significant relationship between the resistin level and inflammatory markers, and reported that levels of adiponectin, resistin and haemoglobin were significantly related to coronary artery aneurysm development in children with Kawasaki disease (49) . CAE has a clinical spectrum ranging from stable angina pectoris to acute coronary syndrome. In addition to atherosclerotic plaque formations accompanying ectatic segments, microembolism to the distal coronary bed, thrombotic occlusion of the ectatic arteries and slow flow phenomenon may be responsible from the clinical picture (50) (51) (52) . Canga et al. detected a significantly higher resistin level in subjects with a slow flow compared to those with a normal coronary blood flow (53) . Dagli et al. reported a significantly lower level of adiponectin, a cardioprotective adipokine, in patients with CAE compared to the control group in a study with 66 subjects. They also found a negative correlation between the diameter of the ectatic coronary artery and plasma adiponectin levels (p= 0.03, r= -0.339) (28) . We similarly found a higher resistin level, which is linked to atherosclerosis, in patients with coronary ectasia than those with normal coronaries. 
Limitations of the Study
Our study has several limitations. Its sample size was relatively small. This is mainly because CAE is a rare disorder when not accompanied by coronary stenosis. In addition, it has a heterogeneous etiologic spectrum, which makes it difficult to collect a sufficient number of cases to form homogenous groups. We were unable to investigate a third control group of subjects with coronary artery disease and without CAE. Our study did not employ intravascular ultrasonography to diagnose patients. This may have flawed our results since intravascular ultrasonography studies have shown that it, along with autopsy studies, may well show diffuse atherosclerotic formations in the vessel wall even when the coronary angiography is found to be normal.
CONCLUSION
CAE and atherosclerosis share common histopathological and clinical characteristics. Resistin, a polypeptide with a known role in the development and clinical presentation of atherosclerosis, may also mediate the formation of CAE. Future studies with a larger sample size are clearly needed to elucidate the effect of resistin on the development of CAE.
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